Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy

Thrombosis Research

Volumn 126, Issue 5, 2010, Pages 379-383

  Nazarian, Susanna M ^a   Thompson, Jason B ^a   Gluckman, Tyler J ^a   Laws, Katherine ^a   Jani, Jayesh T ^a   Kickler, Thomas S ^a   Rade, Jeffrey J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; PFA 100; Platelet hyper reactivity; VonWillebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN; VON WILLEBRAND FACTOR; WARFARIN;

ADULT; AGED; ARTICLE; AUTOANALYZER; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINALYSIS;

ADENOSINE DIPHOSPHATE; ASPIRIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; COHORT STUDIES; COLLAGEN; EPINEPHRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES;

EID: 78149282024     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.04.016     Document Type: Article

References (20)

1. C.P. Hayward, P. Harrison, M. Cattaneo, T.L. Ortel, and A.K. Rao Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function J Thromb Haemost 4 2006 312 319
2. E.J. Favaloro Clinical application of the PFA-100 Curr Opin Hematol 9 2002 407 415
3. J.L. Reny, P. de Moerloose, M. Dauzat, and P. Fontana Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis J Thromb Haemost 6 2008 444 450
4. M. Crescente, A. Di Castelnuovo, L. Iacoviello, G. De Gaetano, and C. Cerletti PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients Thromb Haemost 99 2008 1129 1131
5. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vlcek, and H. Losert Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397
6. P. Harrison, I. Mackie, A. Mathur, M.S. Robinson, Y. Hong, and J.D. Erusalimsky Platelet hyper-function in acute coronary syndromes Blood Coagul Fibrinolysis 16 2005 557 562
7. I. Fuchs, M. Frossard, A. Spiel, E. Riedmuller, A.N. Laggner, and B. Jilma Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2006 2547 2552
8. H. Haubelt, C. Anders, A. Vogt, P. Hoerdt, U.T. Seyfert, and P. Hellstern Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals Br J Haematol 130 2005 759 767
9. T. Chakroun, G. Gerotziafas, F. Robert, C. Lecrubier, M.M. Samama, and M. Hatmi In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor Br J Haematol 124 2004 80 85
10. K.W. von Pape, E. Aland, and J. Bohner Platelet function analysis with PFA-100 in patients medicated with acetylsalicylic acid strongly depends on concentration of sodium citrate used for anticoagulation of blood sample Thromb Res 98 2000 295 299
11. E.J. Heilmann, S.K. Kundu, R. Sio, C. Garcia, R. Gomez, and D.J. Christie Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system Thromb Res 87 1997 159 164
12. E.J. Favaloro Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations Haemophilia 7 2001 170 179
13. T.J. Gluckman, J.B. Segal, S.P. Schulman, E.P. Shapiro, T.S. Kickler, and M.M. Prechel Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery J Thromb Haemost 7 2009 1457 1464
14. Clinical and Laboratory Standards Institute Platelet Function Testing by Aggregometry: Approved Guideline 2008 Clinical and Laboratory Standards Institute Wayne, Pennsylvania 17 19 H58-A[28 (31)]
15. M. Crescente, A. Di Castelnuovo, L. Iacoviello, J. Vermylen, C. Cerletti, and G. De Gaetano Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review Thromb Haemost 99 2008 14 26
16. E.J. Harfenist, M.A. Packham, R.L. Kinlough-Rathbone, M. Cattaneo, and J.F. Mustard Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets Blood 70 1987 827 831
17. R. Donadelli, J.N. Orje, C. Capoferri, G. Remuzzi, and Z.M. Ruggeri Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood Blood 107 2006 1943 1950
18. P.A. Gurbel, K.P. Bliden, J. DiChiara, J. Newcomer, W. Weng, and N.K. Neerchal Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study Circulation 115 2007 3156 3164
19. P. Jilma-Stohlawetz, N. Hergovich, M. Homoncik, L. Dzirlo, M. Horvath, and M. Janisiw Impaired platelet function among platelet donors Thromb Haemost 86 2001 880 886
20. B. Jilma Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 2001 152 163